Martinez V, Baudic S, Fletcher D
Service d'anesthésie-réanimation, hôpital Raymond-Poincaré, Assistance publique-Hôpitaux de Paris, 104, boulevard Raymond-Poincaré, 92380 Garches, France.
Ann Fr Anesth Reanim. 2013 Jun;32(6):422-35. doi: 10.1016/j.annfar.2013.04.012. Epub 2013 Jun 7.
Update reviewing of chronic postsurgical pain.
The following review is based on the English and French literature published in PubMed database between January 1998 and 2013. The research articles were made with following keywords alone or in combination: "chronic pain", "surgery", "postsurgical pain". These keywords were combined with "epidemiology", "incidence", "predictive factors" and "prevention". Study selection Publications were deemed relevant if they contained information about CPSP after 8 weeks post surgery. Animal publications were not included. Only randomized controlled studies were taken into consideration for the pharmacological prevention.
Data extracted were related to epidemiology, impact, predictive factors and prevention of CPSP.
Epidemiology of CPSP is more recognized as it is experienced by 10-50% of individuals after classical operations. CPSP can be severe in about 5 to 10% of these patients. CPSP is a major public health problem still rarely diagnosed and treated. Twenty percent of patients consulting in a pain clinic have a CPSP. The frequency of neuropathic pain is important but the difference in the proportion to CPSP falls between 6-68% and depend on the type of surgery. Clinical risk factors and physiopathology of CPSP are subject of wide development. Human studies allowed better understanding of the neurophysiological as well psychological aspect of the development of CPSP. Finally, the possibility of pharmacological prevention of CPSP seems to have increased in the past years. Nevertheless, there are still many questions that need to be answers about the problem. We should clearly define the optimal characteristics of clinical and experimental studies as this will allow the better understanding of the prevention of CPSP. Anesthesiologists play a crucial role in this development. They are involved in all of the stages of the operative care of patients and play a decisive role in the evaluation of the risk, the development of a preventive strategy, and in the early detection and treatment of CPSP.
更新对慢性术后疼痛的综述。
以下综述基于1998年1月至2013年间在PubMed数据库中发表的英文和法文文献。研究文章仅使用以下关键词单独或组合而成:“慢性疼痛”、“手术”、“术后疼痛”。这些关键词与“流行病学”、“发病率”、“预测因素”和“预防”相结合。研究选择 如果出版物包含术后8周后慢性术后疼痛(CPSP)的相关信息,则被视为相关。不包括动物出版物。仅考虑随机对照研究用于药物预防。
提取的数据与CPSP的流行病学、影响、预测因素和预防有关。
CPSP的流行病学得到了更多认可,因为在经典手术后10%至50%的个体经历过CPSP。在这些患者中,约5%至10%的CPSP可能很严重。CPSP是一个主要的公共卫生问题,仍然很少被诊断和治疗。在疼痛诊所就诊的患者中有20%患有CPSP。神经性疼痛的发生率很重要,但与CPSP的比例差异在6%至68%之间,取决于手术类型。CPSP的临床危险因素和生理病理学是广泛研究的主题。人体研究有助于更好地理解CPSP发生发展的神经生理学以及心理学方面。最后,在过去几年中,药物预防CPSP的可能性似乎有所增加。然而,关于这个问题仍有许多问题需要解答。我们应该明确界定临床和实验研究的最佳特征,因为这将有助于更好地理解CPSP的预防。麻醉医生在这一发展过程中起着至关重要的作用。他们参与患者手术护理的所有阶段,在风险评估、预防策略的制定以及CPSP的早期检测和治疗中起着决定性作用。